抗生素耐药性Helicobacter pylori:在寻找解决方案的全球挑战
Christian Schulz1,2, Jyh-Ming Liou3, Mohamed Alboraie4
1Medical Department 2, LMU Munich, Munich, Germany chr.schulz@med.uni-muenchen.de.
Gut
|July 11, 2025
概括
全球Helicobacter pylori抗生素耐药性正在上升,需要新的管理策略. 除非洲外,阿莫西西林耐药性很低,但在全球范围内,获得有效的木基治疗方法是有限的.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 杆菌 (H. pylori) 的抗生素耐药性是一个日益严重的全球性问题.
- 耐药性增加需要新的策略来控制这种常见的感染.
研究的目的:
- 编制和更新关于*H. pylori*抗生素耐药性 (AR) 率的全球数据.
- 审查当前的*H. pylori*管理策略和相关的公共卫生挑战.
主要方法:
- 在6大洲的31个国家进行了一项国际调查.
- 讨论的主要问题包括AR患病率,抗生素敏感性测试 (AST),药物可用性,补偿和AR监测.
主要成果:
- 在全球范围内,观察到高耐克率的克拉胺素 (>15%在24个国家) 和利沃胺素 (>15%在18个国家).
- 氨基素耐药性通常很低 (在14个国家<2%),在非洲 (>90%) 有显著的例外.
- 基于石的疗法是有效的,但超过10亿人无法获得;诊断测试报销和AR监测计划在全球范围内有限.
结论:
- 越来越多的H. pylori* AR需要紧急重新评估当前的治疗指南.
- 诸如AST指导疗法,新药组合和新药开发等策略对于有效的管理至关重要.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
554
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
554
Development of Antibiotic Resistance
217
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
217
Peptic Ulcer Disease IV: Management
146
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
146
Antibiotic Selection
55.3K
Overview
55.3K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
588
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
588
Gastritis III: Clinical Manifestations and Management
491
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
491


